This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Gan & Lee Pharmaceuticals. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Lingyu Cai: Innovator in Insulin Derivatives
Introduction
Lingyu Cai is a prominent inventor based in Beijing, China. She has made significant contributions to the field of pharmaceuticals, particularly in the development of insulin derivatives. Her innovative work has the potential to improve diabetes management for patients worldwide.
Latest Patents
Lingyu Cai holds a patent for an insulin derivative, which showcases her expertise and dedication to advancing medical science. This patent represents a crucial step in enhancing the efficacy of insulin treatments.
Career Highlights
Cai is currently employed at Gan & Lee Pharmaceuticals, a company known for its commitment to developing high-quality diabetes care products. Her role at the company allows her to apply her knowledge and skills in a practical setting, contributing to the advancement of diabetes therapies.
Collaborations
Lingyu Cai collaborates with esteemed colleagues, including Zhongru Gan and Wei Chen. These partnerships foster a creative environment that encourages innovation and the sharing of ideas.
Conclusion
Lingyu Cai's work in insulin derivatives exemplifies her commitment to improving healthcare solutions for diabetes patients. Her contributions to Gan & Lee Pharmaceuticals and her collaborations with fellow innovators highlight her significant impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile